Insufficient scRNA-seq data for expression of TNFAIP8L3 at single-cell level.
Insufficient scRNA-seq data for expression of TNFAIP8L3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 1449.88 | 571 / 578 | 79% | 4.82 | 912 / 1155 |
esophagus | 100% | 1320.17 | 1439 / 1445 | 75% | 5.37 | 138 / 183 |
uterus | 100% | 5864.25 | 170 / 170 | 73% | 15.65 | 334 / 459 |
breast | 77% | 512.99 | 353 / 459 | 89% | 7.71 | 992 / 1118 |
intestine | 94% | 775.88 | 910 / 966 | 64% | 4.35 | 339 / 527 |
bladder | 100% | 1773.71 | 21 / 21 | 58% | 3.98 | 290 / 504 |
brain | 56% | 450.55 | 1474 / 2642 | 99% | 18.39 | 696 / 705 |
prostate | 78% | 631.47 | 191 / 245 | 72% | 3.66 | 363 / 502 |
ovary | 98% | 1383.96 | 177 / 180 | 39% | 1.70 | 169 / 430 |
skin | 100% | 2241.54 | 1809 / 1809 | 28% | 1.69 | 131 / 472 |
thymus | 86% | 518.45 | 559 / 653 | 38% | 1.63 | 232 / 605 |
stomach | 57% | 404.79 | 204 / 359 | 59% | 3.60 | 168 / 286 |
blood vessel | 100% | 3184.89 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1561.94 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 6.76 | 42 / 45 |
adipose | 93% | 862.98 | 1118 / 1204 | 0% | 0 | 0 / 0 |
kidney | 33% | 169.56 | 29 / 89 | 57% | 8.82 | 517 / 901 |
pancreas | 1% | 3.38 | 3 / 328 | 83% | 6.10 | 147 / 178 |
adrenal gland | 28% | 107.48 | 73 / 258 | 46% | 6.82 | 105 / 230 |
liver | 12% | 47.49 | 28 / 226 | 58% | 3.67 | 236 / 406 |
heart | 51% | 314.78 | 435 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 31% | 0.79 | 9 / 29 |
muscle | 29% | 191.32 | 229 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 9% | 42.30 | 81 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.10 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0120009 | Biological process | intermembrane lipid transfer |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_1902633 | Biological process | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0015914 | Biological process | phospholipid transport |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0008526 | Molecular function | phosphatidylinositol transfer activity |
GO_0005515 | Molecular function | protein binding |
GO_0035091 | Molecular function | phosphatidylinositol binding |
Gene name | TNFAIP8L3 |
Protein name | TNF alpha induced protein 8 like 3 Tumor necrosis factor alpha-induced protein 8-like protein 3 (TNF alpha-induced protein 8-like protein 3) (TNFAIP8-like protein 3) |
Synonyms | TIPE3 |
Description | FUNCTION: Acts as a lipid transfer protein. Preferentially captures and shuttles two lipid second messengers, i.e., phosphatidylinositol 4,5- bisphosphate and phosphatidylinositol 3,4,5-trisphosphate and increases their levels in the plasma membrane. Additionally, may also function as a lipid-presenting protein to enhance the activity of the PI3K-AKT and MEK-ERK pathways. May act as a regulator of tumorigenesis through its activation of phospholipid signaling. . |
Accessions | A0A1B0GTK8 Q5GJ75 ENST00000327536.5 A0A494C051 ENST00000649177.1 ENST00000637513.2 |